Covaxin manufacturing may get a booster shot as demand for vaccines grows

Bharat Biotech also has another site at Bengaluru that is currently making vaccines other than Covaxin

As demand for vaccines grows with states pressing the pedal to increase vaccinations per day, the manufacturing of indigenous vaccine Covaxin may get a boost.

Hyderabad-based vaccine major Bharat Biotech, which is now making 40 million doses of the vaccine per month, has an option to activate another two sites if the need arises — one at Ankleshwar in Gujarat and another at Bengaluru. Both are company-owned sites, a company spokesperson infor­m­ed without divulging further details.  The Mahar­ashtra government too has indicated that 126 million doses of Covaxin can be made at Haffekin Biopharma­ceutical Corporation in Mum­bai, a biomedical research institute,